Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.39 |
| ▸ | CES1 | P23141 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.38 |
| ▸ | PPARG | P37231 | 7/20 | 0.38 |
| ▸ | PPARD | Q03181 | 7/20 | 0.38 |
| ▸ | PPARA | Q07869 | 7/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.38 |
| ▸ | TLR2 | O60603 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | FABP4 | P15090 | 2/20 | 0.38 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11720232 | 1.00 | CES2 (0.39) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL27978205 | 1.00 | CES2 (0.39) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL972921 | 1.00 | CES2 (0.39) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL11720229 | 1.00 | CES2 (0.39) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL11280146 | 0.81 | — | — | |
| SCHEMBL11280138 | 0.81 | — | — | |
| SCHEMBL11717387 | 0.80 | CES2 (0.41) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL11717383 | 0.80 | CES2 (0.41) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL23151826 | 0.78 | CES2 (0.44) | CES2CES1TSHRALDH1A1HSD17B10 | |
| SCHEMBL2638548 | 0.78 | CES2 (0.44) | CES2CES1TSHRALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3649183-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2020-05-13 | — | — | EP | claimed |
| EP-3649184-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2020-05-13 | — | — | EP | claimed |
| WO-2019010265-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-10 | — | — | WO | claimed |
| US-20190010293-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| WO-2019010263-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-10 | — | — | WO | claimed |
| US-20190010427-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | AVOCA LLC | 2011-01-27 | — | — | US | claimed |
| US-11701305-B2 | Unit dose sachet comprising a perfume gel composition | Spritz, Inc. (US) | 2023-07-18 | — | — | US | disclosed |
| EP-4104815-A1 | UNIT DOSE SACHET COMPRISING A PERFUME GEL COMPOSITION | Spr1tz, Inc. (US) | 2022-12-21 | — | — | EP | disclosed |
| US-20220395434-A1 | UNIT DOSE SACHET COMPRISING A PERFUME GEL COMPOSITION | SPR1TZ INC. | 2022-12-15 | — | — | US | disclosed |
| EP-3649184-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2020-05-13 | — | — | EP | disclosed |
| EP-3649183-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2020-05-13 | — | — | EP | disclosed |
| WO-2019010263-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-10 | — | — | WO | disclosed |
| WO-2019010265-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-10 | — | — | WO | disclosed |
| US-8673272-B2 | Ultraviolet-absorbing compounds | ISP INVESTMENTS INC. (US) | 2014-03-18 | — | — | US | disclosed |
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | AVOCA LLC | 2011-01-27 | — | — | US | disclosed |
| EP-1413570-B1 | 5,7,7-Trimethyloctanenitrile | SYMRISE GMBH & CO KG (DE) | 2006-05-10 | — | — | EP | disclosed |
| US-6998378-B2 | 5,7,7-trimethyloctannitril | SYMRISE GMBH & CO. KG (DE) | 2006-02-14 | — | — | US | disclosed |
| US-20040127394-A1 | 5,7,7-Trimethyloctannitril | SYMRISE GMBH & CO. KG (DE) | 2004-07-01 | — | — | US | disclosed |
| EP-1413570-A1 | 5,7,7-Trimethyloctanenitrile | Symrise GmbH & Co. KG (DE) | 2004-04-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | UFM1, UHRF1, CUTA | CES2 2391/4885CES1 3173/4885TSHR 2543/4885 |
| US-20040127394-A1 | 5,7,7-Trimethyloctannitril | API5, TAS2R5, TAAR5 | CES2 705/4885CES1 2151/4885TSHR 4490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.